EYEN Eyenovia Inc.

-0.21  -6%
Previous Close 3.32
Open 3.28
Price To Book 6.91
Market Cap 53,183,258
Shares 17,100,726
Volume 52,987
Short Ratio
Av. Daily Volume 135,999

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 enrolment to be completed end of 2020.
Phase 3 trial not required - plan to proceed with registration activities in 2019.
Dry eye disease
NDA filing due 2020.
Mydriasis - pupil dilation
Phase 3 trial to be initiated late-2019.
Chronic angle closure glaucoma (CACG)

Latest News

  1. Eyenovia, Inc. to Host Earnings Call
  2. Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results
  3. Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
  4. Eyenovia Inc (EYEN) CEO Tsontcho Ianchulev Bought $650,000 of Shares
  5. Eyenovia, Inc. Announces Closing of Public Offering
  6. Did Eyenovia, Inc. (NASDAQ:EYEN) Insiders Buy Up More Shares?
  7. Eyenovia, Inc. Prices Public Offering of Common Stock
  8. Eyenovia, Inc. Announces Proposed Public Offering of Common Stock
  9. Eyenovia Enrolls First Patient in Phase III CHAPERONE Study for Progressive Myopia
  10. Eyenovia Reports First Quarter 2019 Financial Results
  11. Introducing Eyenovia (NASDAQ:EYEN), The Stock That Dropped 33% In The Last Year
  12. Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results
  13. Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results
  14. Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
  15. Eyenovia to Participate in Two Upcoming Investor Conferences
  16. Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis
  17. Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering
  18. Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
  19. Biotech Stocks to Watch